{"database": "openregs", "table": "documents", "rows": [["FDA-2018-D-4533-0614", "FDA", "FDA-2018-D-4533", "Compounding Animal Drugs From Bulk Drug Substances; Draft Guidance\nfor Industry; Availability; Reopening of Comment Period", "Notice", "Extension of Comment Period", "2020-02-20T05:00:00Z", 2020, 2, "2020-02-20T05:00:00Z", null, "2022-01-18T02:00:12Z", "2020-03312", 0, 0, "09000064843927b2"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2018-D-4533-0614"], "units": {}, "query_ms": 10.70012990385294, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}